Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe
The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into new strategic areas and geographies, and support even more entrepreneurs and start-up-companies, thereby strengthening innovation in Denmark and Europe. The new funding frame runs from 2026 to 2035.
Europe faces a critical challenge: The continent produces world-class science, but lacks behind other leading regions in translating discoveries into groundbreaking innovations that create jobs, drive economic growth and address urgent societal challenges.
